Omnicomm Systems (OMCM) 10-K 2 Apr 18 2017 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 29, 2018	Jun. 30, 2017
Document Information [Line Items]
Entity Registrant Name	OMNICOMM SYSTEMS INC
Entity Central Index Key	1,034,592
Trading Symbol	omcm
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		150,209,472
Entity Public Float			$ 19,977,018
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash	$ 1,176,551	$ 1,439,332
Accounts receivable, net of allowance for doubtful accounts of $149,980 and $179,813, respectively	7,492,597	5,455,210
Prepaid expenses	297,131	195,915
Prepaid stock compensation, current portion	0	148,422
Other current assets	11,463	35,055
Total current assets	8,977,742	7,273,934
Property and equipment, net	552,538	637,552
Intangible assets, net	97,925	108,880
Prepaid stock compensation	0	58,663
Other assets	46,714	51,321
TOTAL ASSETS	9,674,919	8,130,350
CURRENT LIABILITIES
Accounts payable and accrued expenses	2,586,045	2,123,073
Deferred revenue, current portion	7,564,587	7,250,061
Convertible notes payable, current portion	50,000	50,000
Patent settlement liability, current portion	112,500	862,500
Total current liabilities	15,439,878	16,610,726
LONG TERM LIABILITIES
Line of credit, long term	2,650,000	2,700,000
Notes payable, related parties, long term, net of current portion, net of discount of $117,365 and $237,664, respectively	282,635	212,336
Notes payable, long term, net of current portion, net of discount of $279,402 and $455,285, respectively	423,098	337,215
Deferred revenue, long term, net of current portion	1,952,366	2,289,169
Convertible notes payable, related parties, long term, net of current portion	5,770,000	5,825,000
Convertible notes payable, long term, net of current portion	350,000	1,175,000
Patent settlement liability, long term, net of current portion	0	108,702
TOTAL LIABILITIES	26,867,977	29,258,148
COMMITMENTS AND CONTINGENCIES (See Note 10)
SHAREHOLDERS' (DEFICIT)
Common stock, 500,000,000 shares authorized, 148,542,805 and 147,786,917 issued and outstanding, respectively, at $0.001 par value	148,544	147,788
Additional paid in capital - preferred	999,750	999,750
Additional paid in capital - common	54,379,454	53,425,956
Accumulated other comprehensive (loss)	(397,237)	(410,505)
Accumulated (deficit)	(72,323,819)	(75,291,037)
TOTAL SHAREHOLDERS' (DEFICIT)	(17,193,058)	(21,127,798)
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	9,674,919	8,130,350
Series A Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series B Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series C Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series D Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	250	250
Conversion Feature Liability Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	1,604,723	1,740,278
Conversion Feature Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	81,224	585,452
Warrant Liability Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	2,196,570	2,519,614
Warrant Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	$ 1,244,229	$ 1,479,748

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Allowance for doubtful accounts	$ 149,980	$ 179,813
Notes payable discount
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares undesignated	$ 3,772,500	$ 3,772,500
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	148,542,805	147,786,917
Common stock, shares outstanding (in shares)	148,542,805	147,786,917
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	230,000	230,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series C Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	747,500	747,500
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series D Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	250,000	250,000
Preferred stock, shares issued (in shares)	250,000	250,000
Preferred stock, shares outstanding (in shares)	250,000	250,000
Related Party Long Term [Member]
Notes payable discount	$ 117,365	$ 237,664
Notes Payable, Other Payables [Member]
Notes payable discount	$ 279,402	$ 455,285

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues	$ 26,067,933	$ 24,394,010
Reimbursable revenues	911,725	1,025,500
Total revenues	26,979,658	25,419,510
Cost of goods sold	4,394,918	3,913,407
Reimbursable expenses-cost of goods sold	885,972	1,461,425
Total cost of goods sold	5,280,890	5,374,832
Gross margin	21,698,768	20,044,678
Operating expenses
Salaries, benefits and related taxes	13,200,837	11,383,727
Rent and occupancy expenses	1,125,147	1,071,363
Consulting services	321,472	185,340
Legal and professional fees	533,221	364,859
Travel	986,092	774,379
Telephone and internet	152,926	164,014
Selling, general and administrative	1,356,427	1,462,774
Bad debt expense	130,346	132,767
Depreciation expense	336,102	302,893
Amortization expense	22,048	37,331
Total operating expenses	18,164,618	15,879,447
Operating income/(loss)	3,534,150	4,165,231
Other income/(expense)
Interest expense, related parties	(947,688)	(918,189)
Interest expense	(419,432)	(421,713)
Interest income	593	2
Change in derivative liabilities	795,779	(2,657,910)
Transaction gain/(loss)	5,010	(64,472)
Income/(loss) before income taxes	2,968,412	102,949
Income tax (expense)	(1,194)	(1,069)
Net income/(loss) attributable to common stockholders	$ 2,967,218	$ 101,880
Net income/(loss) per share
Basic (in dollars per share)	$ 0.02	$ 0
Diluted (in dollars per share)	$ 0.02	$ 0
Weighted average number of shares outstanding
Basic (in shares)	147,865,246	145,868,227
Diluted (in shares)	148,177,984	146,162,427

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Income/Loss) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Net income/(loss) attributable to common stockholders	$ 2,967,218	$ 101,880
Other comprehensive income/(loss)
Change in foreign currency translation adjustment	13,268	(44,150)
Other comprehensive income/(loss)	13,268	(44,150)
Comprehensive income/(loss)	$ 2,980,486	$ 57,730

Consolidated Statement of Share

Consolidated Statement of Shareholders' (Deficit) - USD ($)	Series A Preferred Stock [Member]Preferred Stock [Member]	Series D Preferred Stock [Member]Preferred Stock [Member]	Additional Paid In Capital Preferred [Member]	Common Stock [Member]	Additional Paid In Capital Common [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2015	3,637,724	250,000		131,703,577
Balance at Dec. 31, 2015	$ 3,637	$ 250	$ 4,230,792	$ 131,704	$ 49,974,415	$ (75,392,917)	$ (366,355)	$ (21,418,474)
Employee stock option expense					35,046			35,046
Foreign currency translation adjustment							(44,150)	(44,150)
Restricted stock issuance/(forfeiture) (in shares)				360,000
Restricted stock issuance/(forfeiture)				$ 360	68,040			$ 68,400
Issuance of common stock, stock option exercise (in shares)				1,100,000				1,120,000
Issuance of common stock, stock option exercise				$ 1,100	128,400			$ 129,500
Cashless issuance of common stock, stock option exercise (in shares)				7,644
Cashless issuance of common stock, stock option exercise				$ 8	(8)			0
Issuance of common stock, in exchange for Series A Preferred Stock (in shares)	(3,637,724)			14,615,696
Issuance of common stock, in exchange for Series A Preferred Stock	$ (3,637)		(3,231,042)	$ 14,616	3,220,063			0
Net income/(loss)	$ 0	$ 0	0	$ 0	0	101,880	0	101,880
Balance (in shares) at Dec. 31, 2016	0	250,000		147,786,917
Balance at Dec. 31, 2016	$ 0	$ 250	999,750	$ 147,788	53,425,956	(75,291,037)	(410,505)	(21,127,798)
Employee stock option expense					364,271			364,271
Foreign currency translation adjustment							13,268	13,268
Restricted stock issuance/(forfeiture) (in shares)				(16,668)
Restricted stock issuance/(forfeiture)				$ (17)	(2,817)			$ (2,834)
Issuance of common stock, stock option exercise (in shares)				250,000				300,000
Issuance of common stock, stock option exercise				$ 250	35,000			$ 35,250
Cashless issuance of common stock, stock option exercise (in shares)				22,556
Cashless issuance of common stock, stock option exercise				$ 23	(23)			0
Net income/(loss)	$ 0	$ 0	0	$ 0	0	2,967,218	0	2,967,218
Issuance of common stock, warrant exercise (in shares)				500,000
Issuance of common stock, warrant exercise				$ 500	154,500			155,000
Reclassifiacation of conversion feature liability associated with convertible debt					402,567			402,567
Balance (in shares) at Dec. 31, 2017	0	250,000		148,542,805
Balance at Dec. 31, 2017	$ 0	$ 250	$ 999,750	$ 148,544	$ 54,379,454	$ (72,323,819)	$ (397,237)	$ (17,193,058)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 2,967,218	$ 101,880
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	(795,779)	2,657,910
Interest expense from derivative instruments	296,182	158,068
Employee stock compensation	568,522	222,304
Provision for doubtful accounts	130,346	132,767
Depreciation and amortization	358,150	340,224
Changes in operating assets and liabilities
Accounts receivable	(2,167,733)	(1,495,505)
Prepaid expenses	(101,216)	(25,742)
Other current assets	23,592	(20,704)
Other assets	4,607	(4,756)
Accounts payable and accrued expenses	462,972	615,803
Patent settlement liability	(858,702)	(455,871)
Deferred revenue	(22,277)	291,453
Net cash provided by/(used in) operating activities	865,882	2,517,831
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(242,384)	(260,378)
Net cash (used in) investing activities	(242,384)	(260,378)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(915,000)	(200,000)
Repayments of notes payable, related parties	(105,000)	(45,000)
Proceeds/(repayments) from revolving line of credit	(50,000)	(1,500,000)
Proceeds from Stock Options Exercised	35,250	129,500
Proceeds from exercise of warrants	155,000	0
Net cash provided by/(used in) financing activities	(879,750)	(1,615,500)
Effect of exchange rate changes on fixed and intangible assets	(19,797)	6,310
Effect of exchange rate changes on cash and cash equivalents	13,268	(44,150)
Net increase/(decrease) in cash and cash equivalents	(262,781)	604,113
Cash and cash equivalents at beginning of period	1,439,332	835,219
Cash and cash equivalents at end of period	1,176,551	1,439,332
Supplemental disclosures of cash flow information:
Income taxes	1,194	1,069
Interest	1,051,909	1,445,684
Non-cash transactions:
Notes payable issued in exchange for existing notes payable	350,000	7,652,500
Restricted stock issuance/(forfeiture)	(2,834)	68,400
Common stock issued in exchange for 5% Series A Preferred Stock	0	3,637,724
Reclassification of conversion feature liability associated with convertible debt	402,567	0
Promasys B.V. [Member]
Non-cash transactions:
Promissory notes issued for accrued interest	$ 0	$ 450,000

Note 1 - Organization and Natur

Note 1 - Organization and Nature of Operations	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Nature of Operations [Text Block]	NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare te chnology company that provides web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotechnology companies, contract research organizations (“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster ® ; TrialOne ® ™ ® ; and eClinical Suite ™ Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services. Our research and product development efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. During the year ended December 31, 2017 $2,854,428 December 31, 2016 $2 ,598,962

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt and warrants issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may RECLASSIFICATIONS Certain reclassifications have been made in the 2016 2017 not FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $13,268 December 31, 2017 $44,150 December 31, 2016. REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , IRTMaster, Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: ( 1 there is persuasive evidence of an arrangement; ( 2 3 4 The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2017 December 31, 2016, For the year ended Revenue activity December 31, 2017 December 31, 2016 Set-up fees $ 4,981,941 $ 6,658,987 Change orders 1,540,167 1,212,153 Maintenance 5,107,787 4,803,171 Software licenses 10,658,977 7,885,023 Professional services 3,359,554 3,843,641 Hosting 1,331,232 1,016,535 Total $ 26,979,658 $ 25,419,510 COST OF GOOD S SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value. ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $149,980 December 31, 2017 $179,813 December 31, 2016. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2017 December 31, 2016 Beginning of period $ 179,813 $ 116,834 Bad debt expense 130,346 132,767 Write-offs (160,179 ) (69,788 ) End of period $ 149,980 $ 179,813 CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2017, $755,893 Except as follows, the Company has no December 31, 2017. December 31, 2017, no not One customer accounted for 10% December 31, 2017 $2,691,000. 16% December 31, 2016 $4,167,000. 10% One customer accounted for approximately 24% as of December 31, 2017. 11% December 31, 2016. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2017 1 10% 1 24% December 31, 2016 1 16% 2 21% The table below provides revenues from European customers for the years ended December 31, 2017 December 31, 2016. European revenues For the year ended December 31, 2017 December 31, 2016 European revenues % of Total revenues European revenues % of Total revenues $3,632,537 14% $2,702,660 11% The Company serves all of its hosting customers from third not third may PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value. DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2017, $9,516,953 1 5 $7,564,587 twelve ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $701,161 December 31, 2017 $712,179 December 31, 2016 RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, not 985.20. December 31, 2017 $2,854,428 December 31, 2016 $2,598,962, third EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 31, 2017 10,500,000 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7.5 2009 Each plan is more fully described in “Note 1 3, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value. EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established , when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. On December 22, 2017, 21 January 1, 2018. 740, Income Taxes December 31, 2017, 2l 14. IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2017, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842 2016 02” 12 December 15, 2019. In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08” 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10” 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20” 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, In July 2017, 2017 11 Earnings per Share (Topic 260 480 815 2017 11” 480 not 2017 11 December 15, 2018, 2017 11. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 3 - Earnings (Loss) Per Sh

Note 3 - Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 3: EARNINGS/(LOSS) PER SHARE Basic income/(loss) per share was calculated using the weighted average number of shares outstanding of 147,865,246 December 31, 2017 145,868,227 December 31, 2016. Antidilutive shares aggregating 43,343,224 December 31, 2017 43,775,016 December 31, 2016 December 31, 2017 December 31, 2016. Anti-dilutive security December 31, 2017 December 31, 2016 Employee stock options 4,225,000 275,000 Warrants 27,020,000 27,860,000 Convertible notes 11,980,000 15,490,000 Shares issuable for accrued interest 118,224 150,016 Total 43,343,224 43,775,016 The employee stock options are exercisable at prices ranging from $0. 17 $0.34 $0.25 $0.60 $0.25 $1.25 Provided below is the reconciliation between numerators and denominators of the basic and diluted income/(loss) per shares. For the year ended December 31, 2017 December 31, 2016 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 2,967,218 147,865,246 $ 0.02 $ 101,880 145,868,227 $ 0.00 Effect of dilutive securities 4,766 312,738 -0- -0- 294,200 -0- Diluted EPS $ 2,971,984 148,177,984 $ 0.02 $ 101,880 146,162,427 $ 0.00

Note 4 - Property and Equipment

Note 4 - Property and Equipment, Net	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4 : PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: December 31, 2017 December 31, 2016 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,322,833 $ 1,949,982 $ 372,851 $ 2,125,067 $ 1,761,879 $ 363,188 5 Leasehold improvements 118,380 98,901 19,479 114,719 89,789 24,930 5 Computer software 2,010,999 1,886,342 124,657 1,925,462 1,720,399 205,063 3 Office furniture 162,799 127,248 35,551 158,436 114,065 44,371 5 Total $ 4,615,011 $ 4,062,473 $ 552,538 $ 4,323,684 $ 3,686,132 $ 637,552 Depreciation expense was $336,102 December 31, 2017 $302,893 December 31, 2016.

Note 5 - Intangible Assets, Net

Note 5 - Intangible Assets, Net	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 5 : INTANGIBLE ASSETS, NET Intangible assets consist of the following: December 31, 2017 December 31, 2016 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 118,780 32,994 85,786 104,163 21,990 82,173 15 Promasys B.V. software code 72,837 60,698 12,139 72,837 46,130 26,707 5 Promasys B.V. URLs/website 59,990 59,990 -0- 52,608 52,608 -0- 3 Total $ 1,644,308 $ 1,546,383 $ 97,925 $ 1,622,309 $ 1,513,429 $ 108,880 Amortization expense was $ 22,048 December 31, 2017 $37,331 December 31, 2016. Annual amortization expense for the Company ’s intangible assets is as follows: Year Amortization 2018 $ 20,058 2019 7,919 2020 7,919 2021 7,919 2022 7,919 Thereafter 46,191 Total $ 97,925

Note 6 - Accounts Payable and A

Note 6 - Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 6 : ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account December 31, 2017 December 31, 2016 Accounts payable $ 1,303,073 $ 697,060 Accrued payroll and related costs 925,890 886,334 Other accrued expenses 184,131 431,961 Accrued interest 172,951 107,718 Total accounts payable and accrued expenses $ 2,586,045 $ 2,123,073

Note 7 - Line of Credit, Notes

Note 7 - Line of Credit, Notes Payable and Liquidity	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 7: LINE OF CREDIT, NOTES PAYABLE AND LIQUIDITY On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. April 7, 2017 April 7 , 2020 December 31, 2017, $2,650,000 3.5%. Our primary sources of working capital are funds from operations and borrowings under our Line of Credit. In the event that the Line of Credit is called for any reason, Mr. Wit has pledged to replace the borrowing capacity under the Line of Credit with a promissory note that utilizes the same maturity date and interest rate as the Line of Credit. To satisfy our capital requirements, we may no not may research and product development and marketing programs. If we are successful in obtaining additional financings, the terms of such financings may At December 31, 2017, $1,102,500 Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2017 Current term Current term 2/29/2016 4/1/2019 12% $ 400,000 $ -0- $ -0- $ -0- $ 400,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 282,500 -0- 282,500 -0- -0- Discount on notes payable -0- (279,402 ) -0- (117,365 ) Total $ 1,102,500 $ -0- $ 423,098 $ -0- $ 282,635 At December 31, 2016, $1,242,500 Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336 On April 1, 2015 $20,000 12% April 1, 2018. O December 14, 2016 t $20,000 . On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On December 5, 2016 1,000,000 August 31, 2017 $50,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $325,689 $124,311. 37 On June 30, 2016, $372,500 1,490,000 $0.25 April 1, 2020 two 12% April 1, 2020. On August 31 , 2017 $90,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $246,921 $125,579. 45 On June 30, 2016, $420,000 1,680,000 $0.25 April 1, 2020 two 10% April 1, 2020. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $278,408 $141,592. 45

Note 8 - Convertible Notes Paya

Note 8 - Convertible Notes Payable	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Convertible Debt Disclosure [Text Block]	NOTE 8: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of December 31, 2017. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2017 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2019 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 6,170,000 $ -0- $ 50,000 $ 5,770,000 $ 350,000 The following table summarizes the convertible debt outstanding as of December 31, 2016. Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000 10% During 1999 10% $862,500 There were costs of $119,625 $742,875. 10% June 30, 2004, $1.25 December 31, 2017, $812,500 1,495,179 $50,000. $93,210 December 31, 2017. Secured Convertible Debentures On September 30, 2009 $1,400,000 12% 5,600,000 $0.25 four four Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”). The Company received net proceeds of $1,400,000. 12% March 30, 2011. $0.25 On March 30, 2011 $200,000 $1,200,000 Debentures until April 1, 2013, $1,100,000 On February 22, 2013 and two $1,200,000 January 1, 2016, $1,100,000 January 1, 2016. On January 31, 2015 $1,100,000 April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two On April 1, 2015 holder extended the maturity date of $100,000 April 1, 2018. April 1, 2018. June 30, 2017 $100,000 On June 30, 2016 two $625,000 April 1, 2020. April 1, 2020. In August 2017 $625,000 Convertible Debentures August 2008 On August 29, 2008 $2,270,000 4,540,000 four Chief Executive Officer and Director, Cornelis F. Wit and one 10% August 29, 2010. $0.50 On September 30, 2009 the Company and two $1,920,000 August 29, 2013 On February 22, 2013 $1,770,000 f the convertible debentures to January 1, 2016. January 1, 2016. On February 22, 2013 Director, Guus van Kesteren (“Mr. van Kesteren”) $150,000 to January 1, 2015. January 1, 2015. On April 21, 2014 the Company and Mr. van Kesteren extended the maturity date of $150,000 April 1, 2016. April 1, 2016. July 31, 2014 $150,000 On January 31, 2015 1,770,000 April 1, 2017. April 1, 2017. On June 30, 2015 $150,000 o April 1, 2017. April 1, 2017. On June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. On June 30, 2016 $150,000 April 1, 2018. April 1, 2018. On June 30, 201 7 $150,000 April 1, 2019. April 1, 2019. December 2008 On December 16, 2008 the Company sold $5,075,000 10,150,000 eleven four 12% December 16, 2010. $0.50 On September 30, 2009 the Company and eight $4,980,000 December 16, 2013 On February 22, 2013 holders extended the maturity date of $4,505,000 $4,475,000 $25,000 $5,000 January 1, 2016. January 1, 2016. On May 1, 2015 the $5,000 of convertible debentures to Mr. Smith were repaid in full. On February 27, 2013 $15,000 to January 1, 2016. January 1, 2016. On March 6, 2013 holder extended the maturity date of $200,000 January 1, 2014. January 1, 2014. On March 12, 2013 holder extended the maturity date of $100,000 January 1, 2015. January 1, 2015. In December 2013 mpany and two $360,000 $160,000 January 1, 2016. January 1, 2016. July 31, 2014 $160,000 On April 28, 2014 the Company and the holder extended the maturity date of $100,000 April 1, 2016. April 1, 2016. On January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 On April 27, 2015 $200,000 pril 1, 2018. April 1, 2018. On April 30, 2015 $25,000 April 1, 2018. April 1, 2018. $25,000 December 14, 2016. On May 1, 2015 Mr. van Kesteren extended the maturity date of $160,000 April 1, 2017. April 1, 2017. On May 7, 2015 the Company and Mr. Veatch extended the maturity date of $15,000 pril 1, 2018. April 1, 2018. $15,000 December 14, 2016. On June 30, 2015 the Company and the holder extended the maturity date of $100,000 April 1, 2017. April 1, 2017. On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. On August 31, 2017 $55,000 On June 30, 2016 $160,000 April 1, 2018. April 1, 2018. The $160,000 December 14, 2016. On June 30, 2016 $100,000 April 1, 2020. April 1, 2020. The $100,000 August 31, 2017. On June 30, 2017 $200,000 April 1, 2021. April 1, 2021. The payments required at maturity under the Company ’s outstanding convertible debt at December 31, 2017 Year Amount 2018 $ 50,000 2019 150,000 2020 5,770,000 2021 200,000 Total $ 6,170,000

Note 9 - Fair Value Measurement

Note 9 - Fair Value Measurement	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 9 : FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, 820 not ASC 820 820 ● Level 1: ● Level 2: ces for similar assets or liabilities or market-corroborated inputs; and ● Level 3: no the assets or liabilities. The valuation techniques that may ● Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilit ies ● Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method ● Cos t approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost) The Company also adopted the provisions of ASC 825, ASC 825 may not not December 31, 2017 December 31, 2016. The Company ’s financial assets or liabilities subject to ASC 820 December 31, 2017 2008 2009, 2011 2016 2013. not not 815 Disclosures about Derivative Instruments and Hedging Activities 8 Following is a description of the valuation methodologies used to determine the fair value of the Company ’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy. A summary as of December 31, 2017 Fair value at Quoted prices in active markets for identical assets/liabilities Significant other observable inputs Significant unobservable inputs December 31, 2017 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 1,685,947 $ -0- $ -0- $ 1,685,947 Warrant liability 3,440,799 -0- -0- 3,440,799 Total of derivative liabilities $ 5,126,746 $ -0- $ -0- $ 5,126,746 ( 1 December 31, 2017 ( 2 Significant valuation assumptions for derivative instruments at December 31, 2017 Risk free interest rate 1.56% to 1.81% Dividend yield 0.00% Expected volatility 87.0% to 118.4% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 A summary as of December 31, 2017 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2016 December 31, 2017 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 82,173 $ 85,786 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 26,707 12,139 -0- -0- 72,943 Total $ 108,880 $ 97,925 $ -0- $ -0- $ 209,196 ( 3 ( 4 not A summary as of December 31, 2016 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2016 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092 ( 1 December 31, 2016 ( 2 Significant valuation assumptions for derivative instruments at December 31, 2016 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 A summary as of December 31, 2016 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 December 31, 2016 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010 ( 3 ( 4 not Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 15 may not Other income/(expense) For the year ended December 31, 2017 December 31, 2016 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gain/(losses) from changes in derivative liabilities at the reporting date $ 795,779 $ (2,657,910 ) Total unrealized and realized gains/(losses) included in earnings $ 795,779 $ (2,657,910 ) The tables below set forth a summary of changes in fair value of the Company ’s Level 3 December 31, 2017 December 31, 2016. 3 December 31, 2017 December 31, 2016. Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, For the year ended beginning Net realized Net unrealized and associated with end December 31, 2017 of year gains/(losses) gains/(losses) settlements convertible debt of year Derivatives: Conversion feature liability $ (2,325,730 ) $ 48,375 $ 188,841 $ -0- $ 402,567 $ (1,685,947 ) Warrant liability (3,999,362 ) -0- 558,563 -0- -0- (3,440,799 ) Total of derivative liabilities $ (6,325,092 ) $ 48,375 $ 747,404 $ -0- $ 402,567 $ (5,126,746 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 )

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 1 0 : COMMITMENTS AND CONTINGENCIES The Company currently leases office space under operating leases for its office locations and has several operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at December 31, 2017 Year Payments 2018 $ 651,376 2019 475,638 2020 339,287 2021 269,962 2022 266,000 Thereafter 44,549 Total $ 2,046,812 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $1,125,147 December 31, 2017 $1,071,363 December 31, 2016. The Company ’s corporate office lease expires in February 2023. March 2021. September 2020. July 2018. October 2018. LEGAL PROCEEDINGS From time to time the Company may December 31, 2017, no PATENT LITIGATION SETTLEMENT Effective April 2, 2009, June 18, 2008 No. 6,496,827 B2 , and (ii) released us from any and all claims of infringement of the Licensed Patent which may may January 1, 2008 December 31, 2017 two 2% thirty 30 thirty 30 In addition and as a license fee for past use of the Licensed Patent which may 1,000,000 $.01 $300,000. second April 2, 2011, December 31, 2017. December 31, 2017 50% 500,000 50% 500,000 $145,000. The remaining minimum royalty payments per year are as follows: Year Payment 2018 $ 112,500 Total $ 112,500 On June 23, 2009, Concurrent with the consummation of that transaction we entered into the First Amendment to Settlement and Licensing Agreement with DataSci, (i) to include the eResearch Technology EDC assets acquired within the definition of Licensed Products, and as such subject to the royalty payment(s), under and in accordance with the Settlement and Licensing Agreement, and (ii) provide a release by DataSci of any and all claims of infringement of the Licensed Patent in connection with the eResearch Technology EDC assets acquired which may $300,000. The Company recorded a credit to earnings of $108,702 December 31, 2017 $94,129 December 31, 2016, 1 December 31, 2017 December 31, 2016 2 EMPLOYMENT AGREEMENTS The Company has employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Executive Chairman Randall G. Smith, Executive Vice Chairman Stephen E. Johnson, Chief Executive Officer Thomas E. Vickers, Chief Financial Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one ninety the Company may 30 may

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 1 1 : RELATED PARTY TRANSACTIONS On April 1, 2015 $20,000 (“Mr. Smith”), in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% April 1, 2018. December 14, 2016. On April 30, 2015, $25,000 December 2008. 12% April 1, 2018. April 1, 2018. The convertible debentures were repaid in full on December 14, 2016. As of December 31, 2017, $5,770,000 $400,000 ● In June 2008, $510,000 August 29, 2008, $510,000 $1,260,000 3,540,000 10% August 29, 2010. $0.50 September 30, 2009, $1,770,000 August 29, 2013 February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. ● In February 2008, $150,000 September 2008 December 2008, $4,200,000 December 16, 2008, $4,350,000 8,700,000 12% December 16, 2010. $0.50 September 30, 2009, $4,350,000 December 16, 2013 October 16, 2012, $125,000 December 2008 250,000 February 22, 2013, $4,475,000 January 1, 2016. January 1, 2016. January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 . On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. August 31, 2017, $55,000 ● On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On August 31, 2017, $5 0,000 On March 18, 2013, $2,000,000 guaranteed by Mr. Wit. On December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. April 7, 2017 2.0% $9,500 April 7, 2020 December 31, 2017, $2,650,000 3.5%. The Company incurred interest expense payable to related parties of $947,688 December 31, 2017 $918,189 December 31, 2016.

Note 12 - Stockholders' (Defici

Note 12 - Stockholders' (Deficit)	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 1 2 : STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 5 00,000,000 $.001 10,000,000 $.001 5,000,000 5% 230,000 747,500 250,000 As of December 31, 2017 ● 148,542,805 shares of common stock issued and outstanding; ● 27,020,000 warrants issued and outstanding to purchase shares of our common stock; ● 5,275,000 ● 250,000 ● $ 6,170,000 12 ,28 0,000 Common Stock Holders of common stock are entitled to one Holders of our voting securities do not Holders of common stock have no no The rights of the holders of common stock are subject to any rights that may During the first four 2016 14,615,696 On A pril 13, 2016 3,012 On A pril 25, 2016 1,000,000 On A pril 26, 2016 1,594 On June 1 6, 2016 360,000 2009 3 On July 20, 2016 3,038 On December 30, 2016 2011. 100,000 On March 24, 2017 16,668 On June 26, 2017 22,556 On A ugust 2, 2017 2012. 100,000 On September 29, 2017 50,000 On September 29, 2017 2012. 100,000 On December 31, 2017 50% 500,000 The 2009 1 3, Preferred stock Our Board of Directors, without further stockholder approval, may one may ● dividend and liquidation preferences, ● voting rights, ● conversion privileges, and ● redemption terms. Our Board of Directors may In addition, our Board of Directors can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding. The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of December 31, 2017 December 31, 2016 Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2017 2016 2017 2016 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980 Series A Preferred Stock In 1999, 5,000,000 5% - 0 The designations, rights and preferences of the Series A Preferred include: ● the shares are not ● each share of Series A Preferred Stock is convertible into shares of our common stock at any time at the option of the holder at a conversion price of $1. 11 not one $3.00 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share. The Series A Preferred Stockholders have waived their rights to an anti-dilution adjustment reducing their conversion price as a result of the issuance of the Series B Preferred Stock and Series C Preferred Stock, ● the shares of Series A Preferred Stock pay a cumulative dividend at a rate of 5% $1.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series A Preferred Stock has a liquidation preference equal to $1.00 and ● the holders of the Series A Preferred Stock are entitled to vote together with the holders of our common stock, on the basis of one In addition, the holders of the Series A Preferred Stock were granted certain demand and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series A Preferred Stock. Prior to 2015 235,000 5% In December 2015 the Company initiated an Exchange Offer to the remaining 34 4 December 31, 2015 four 5% 487,500 1,950,000 first 4 2016, 3,637,724 14,615,696 Series B Preferred Stock In August 2001, 200,000 February 7, 2002 230,000 0 The designations, rights and preferences of the Series B Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not ● each share of Series B Preferred Stock is convertible into shares of our common stock at the option of the holder at any time commencing January 31, 2002 $0.25 $0.25 $25 $0.75 We may $0.50 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series B Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series B Preferred Stock, ● each share of Series B Preferred Stock will rank senior to our Series A Preferred and pari passu with our Series C Preferred Stock, ● in the event of our liquidation or winding up, each share of Series B Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series B Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $609,887 $609,887, $3.05 $3.05 December 31, 2017 December 31, 2016, The Company has 200,000 stockholders into shares of our common stock. Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our Board of Directors. In addition, the holders of the Series B Preferred Stock were granted certain mandatory and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series B Preferred Stock and were entitled to vote one Series C Preferred Stock In March 2002, 747,500 0 The designations, rights and preferences of the Series C Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not ● each share of Series C Preferred Stock is convertible at any time, at the option of the holder, into a number of shares of common stock determined by dividing the stated value per share of the Series C Preferred Stock by $0.25, The Series C Preferred Stock will automatically convert, subject to limitations based on trading volume, into shares of our common stock upon a public offering of our securities raising gross proceeds in excess of $25,000,000 2.5 two 20 not 30 10 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series C Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series C Preferred Stock, ● each share of Series C Preferred Stock will rank pari passu with our Series B Preferred Stock and senior to our Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series C Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series C Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $1,472,093 $1,472,093, $4.3 7 $4.37 December 31, 2017 December 31, 2016, The Company has 337,150 stockholders into shares of our common stock. Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our Board of Directors. In addition, the holders of the Series C Preferred Stock were granted certain mandatory and piggy-back registration rights covering the shares of our common stock issuable upon the conversion of the Series C Preferred Stock and were entitled to vote two Series D Preferred Stock In November 2010, 250,000 250,000 The designations, rights and preferences of the Series D Preferred Stock include: ● the stated value of the Series D Preferred is $0.001 ● the Series D Preferred has no the holders of its common stock, ● the shares of Series D Preferred are not her security of the Corporation, ● except as provided in Series D Preferred Designation, in the case of the death or disability of Series D Preferred holder, the Series D Preferred is not ssued shares of preferred stock, ● each share of Series D Preferred entitles the holder to four hundred 400 ● in the event of the liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the holders of shares of the Series D Preferred then outstanding are entitled to receive before holders of shares of common stock receive any amounts, out of the remaining assets of the Corporation available for distribution to its stockholders, an amount equal to $0.001 r share, ● so long as any shares of Series D Preferred are outstanding, the Company cannot without first res of Series D Preferred Stock, ● the holders of the Series D Preferred are not any class, ● the Company has a thirty 30 first The Company must purchase all of those shares of Series D Preferred offered by the holder of the Series D Preferred Stock, and ● the holders of Series D Preferred cannot, directly or indirectly, transfer any shares of Series D Preferred. Any such purported transfer shall be of no not Warrants Issued for Services and in Capital Transactions The following tables summarize all warrants issued as part of debt transactions for the year s ended December 31, 2017 December 31, 2016, December 31, 2017 December 31, 2017 Warrants outstanding Warrants exercisable Weighted average Weighted Weighted Range of exercise price Number outstanding remaining contractual life average exercise price Number exercisable average exercise price $0.25 – $0.60 27,020,000 1.84 $ 0.42 27,020,000 $ 0.42 December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted Weighted Range of exercise price Number outstanding remaining contractual life average exercise price Number exercisable average exercise price $0.25 – $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42 Warrants Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Issued -0- Exercised -0- Expired/forfeited (840,000 ) Balance at December 31, 2017 27,020,000 Warrants exercisable at December 31, 2017 27,020,000 Weighted average fair value of warrants granted during 2017 n/a Other Comprehensive (Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no The following table lists the beginning balance, yearly activity and ending balance of the components of accumulated other comprehensive (loss). Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2015 $ (366,355 ) $ (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 (410,505 ) (410,505 ) 2017 Activity 13,268 13,268 Balance at December 31, 2017 $ (397,237 ) $ (397,237 )

Note 13 - Employee Equity Incen

Note 13 - Employee Equity Incentive Plans	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 1 3 : EMPLOYEE EQUITY INCENTIVE PLANS Stock Option Plan s Description of 2016 In 2016, ’s Board of Directors and stockholders approved the OmniComm Systems, Inc. 2016 “2016 2016 2016 10,000,000 2016 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 2016 June 29, 2026. As of December 31, 2017 10,500,000 The maximum term for any option grant under the 2016 ten 2016 five 2016 two first 50% one second second 2016 three Any unvested stock options or restricted shares with restrictions that have not 2016 As of December 31, 2017, 4,900,000 0 2016 December 31, 2017, 5,600,000 2016 Description of 2009 In 2009, ’s Board of Directors and stockholders approved the 2009 “2009 2009 2009 7,500,000 The maximum term for any op tion grant under the 2009 ten 2009 five 2009 two first 50% one second second 2009 three Any unvested stock options or restricted shares with restrictions that had not 2009 2009 2016 No 2009 As of December 31, 2017, 375,000 3,876,662 2009 December 31, 2017, 0 2009 The following table summarizes the stock option activity for the Company ’s equity incentive plans: Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2015 2,002,500 $ 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 0.17 2.62 $ 83,425 Granted 4,650,000 0.26 Exercised (300,000 ) 0.13 Forfeited/cancelled/expired (300,000 ) 0.14 Outstanding at December 31, 2017 5,275,000 $ 0.26 4.09 $ 130,475 Vested and exercisable at December 31, 2017 400,000 $ 0.19 1.42 $ 32,638 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company ’s closing stock price at fiscal year-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2017. The total number of shares vested and the fair value of shares vested for the years ended December 31, 2017 December 31, 2016, Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2017 62,500 $ 12,742 December 31, 2016 162,500 $ 33,622 Cash received from stock option exercises for the year ended December 31, 2017 $35,250 $129,500 December 31, 2016. no December 31, 2017 December 31, 2016. The following table summarizes information concerning options outstanding at December 31, 2017: Awards breakdown by price range at December 31, 2017 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 300,000 1.93 $ 0.18 250,000 1.48 $ 0.17 0.21 to 0.30 4,250,000 4.12 0.25 150,000 1.30 0.22 0.31 to 0.50 725,000 4.82 0.34 -0- 0.00 0.00 0.00 to 0.50 5,275,000 4.09 $ 0.26 400,000 1.42 $ 0.19 The following table summarizes information concerning options outstanding at December 31, 2016: Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.30 375,000 3.70 0.23 112,500 1.67 0.21 0.31 to 0.50 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.50 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15 The weighted average fair value (per share) of options granted during the year ended December 31, 2017 $0.21 $0.19 December 31, 2016 Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company ’s commercialization activities were initiated during the second 2000. 2017 2016. may The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. The fair value of share-based payments was estimated using the Black Scholes option pricing model with the following assumptions for grants made during the periods indicated. For the year ended Stock option assumptions December 31, 2017 December 31, 2016 Risk-free interest rate 1.81% 1.45% Expected dividend yield 0.0% 0.0% Expected volatility 127.1% 155.5% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value for the Company incentive stock plans: Weighted average grant date fair value for the year ended December 31, 2017 2016 Stock options granted during the period $ 0.21 $ 0.19 Stock options vested during the period $ 0.20 $ 0.21 Stock options forfeited during the period $ 0.13 $ 0.28 A summary of the status of the Company ’s non-vested shares underlying stock options as of December 31, 2017, December 31, 2017 Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2017 487,500 $ 0.19 Nonvested shares at December 31, 2017 4,875,000 $ 0.21 As of December 31, 2017, $656,978 2.08

Note 14 - Income Taxes

Note 14 - Income Taxes	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 1 4 : INCOME TAXES A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to the income before provision for income taxes is as follows : December 31, 2017 December 31, 2016 Federal statutory rate applied to income/(loss) before income taxes $ 1,117,014 $ 38,740 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,194 1,069 Nondeductible expenses (44,845 ) 1,078,519 Change in deferred assets (35,423 ) 41,019 Change in valuation allowance (1,036,746 ) (1,158,278 ) Income tax expense/(benefit) $ 1,194 $ 1,069 The components of income tax expense /(benefit) for the year ended: December 31, 2017 December 31, 2016 Current tax expense/(benefit): $ 1,194 $ 1,069 Deferred tax expense/(benefit): Bad debt allowance 11,226 (23,699 ) Operating loss carryforward 1,060,942 1,140,957 Amortization of intangibles 5,482 5,482 Patent litigation settlement (40,904 ) 35,538 1,037,940 1,159,347 Valuation allowance (1,036,746 ) (1,158,278 ) Total tax expense/(benefit) $ 1,194 $ 1,069 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows: December 31, 2017 December 31, 2016 Amortization of intangibles $ 261,771 $ 267,253 Bad debt allowance 55,436 66,662 Patent litigation liability accrual 169,709 128,804 Impact of the Tax Cuts and Jobs Act (1,699,440 ) -0- Operating loss carryforwards 17,973,631 19,034,573 Gross deferred tax assets 16,761,107 19,497,292 Valuation allowance (16,761,107 ) (19,497,292 ) Net deferred tax liability/(asset) $ -0- $ -0- The Company has net operating loss carry forwards (NOL) for income tax purposes of approximately $ 32,543,685. 2037 1998. December 31, 2017. December 31, 2017 $2,736,185. three On December 22, 2017, 2018 21 January 1, 2018. $1,699,440, $1,699,440 December 31, 2017.

Note 15 - Subsequent Events

Note 15 - Subsequent Events	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 1 5 : SUBSEQUENT EVENTS Subsequent to December 31, 2017 $1,750,000 Subsequent to December 31, 2017 $500,000 1,666,667 Subsequent to December 31, 2017 2017 not

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt and warrants issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may
Reclassification, Policy [Policy Text Block]	RECLASSIFICATIONS Certain reclassifications have been made in the 2016 2017 not
Foreign Currency Transactions and Translations Policy [Policy Text Block]	FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $13,268 December 31, 2017 $44,150 December 31, 2016.
Revenue Recognition, Policy [Policy Text Block]	REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , IRTMaster, Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: ( 1 there is persuasive evidence of an arrangement; ( 2 3 4 The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2017 December 31, 2016, For the year ended Revenue activity December 31, 2017 December 31, 2016 Set-up fees $ 4,981,941 $ 6,658,987 Change orders 1,540,167 1,212,153 Maintenance 5,107,787 4,803,171 Software licenses 10,658,977 7,885,023 Professional services 3,359,554 3,843,641 Hosting 1,331,232 1,016,535 Total $ 26,979,658 $ 25,419,510
Cost of Sales, Policy [Policy Text Block]	COST OF GOOD S SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs .
Cash and Cash Equivalents, Policy [Policy Text Block]	CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.
Receivables, Policy [Policy Text Block]	ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $149,980 December 31, 2017 $179,813 December 31, 2016. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2017 December 31, 2016 Beginning of period $ 179,813 $ 116,834 Bad debt expense 130,346 132,767 Write-offs (160,179 ) (69,788 ) End of period $ 149,980 $ 179,813
Concentration Risk, Credit Risk, Policy [Policy Text Block]	CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2017, $755,893 Except as follows, the Company has no December 31, 2017. December 31, 2017, no not One customer accounted for 10% December 31, 2017 $2,691,000. 16% December 31, 2016 $4,167,000. 10% One customer accounted for approximately 24% as of December 31, 2017. 11% December 31, 2016. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2017 1 10% 1 24% December 31, 2016 1 16% 2 21% The table below provides revenues from European customers for the years ended December 31, 2017 December 31, 2016. European revenues For the year ended December 31, 2017 December 31, 2016 European revenues % of Total revenues European revenues % of Total revenues $3,632,537 14% $2,702,660 11% The Company serves all of its hosting customers from third not third may
Property, Plant and Equipment, Policy [Policy Text Block]	PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805” 350, Intangibles- Goodwill and Other 350” The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value.
Revenue Recognition, Deferred Revenue [Policy Text Block]	DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2017, $9,516,953 1 5 $7,564,587 twelve
Advertising Costs, Policy [Policy Text Block]	ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $701,161 December 31, 2017 $712,179 December 31, 2016
Research, Development, and Computer Software, Policy [Policy Text Block]	RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, not 985.20. December 31, 2017 $2,854,428 December 31, 2016 $2,598,962, third
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. 2016 10,000,000 2016 January 1st nine 9 January 1, 2017 January 1, 2025, five 5% 2016 31, 2017 10,500,000 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 2009 7.5 2009 Each plan is more fully described in “Note 1 3, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value.
Earnings Per Share, Policy [Policy Text Block]	EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities.
Income Tax, Policy [Policy Text Block]	INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established , when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. On December 22, 2017, 21 January 1, 2018. 740, Income Taxes December 31, 2017, 2l 14.
New Accounting Pronouncements, Policy [Policy Text Block]	IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2017, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842 2016 02” 12 December 15, 2019. In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08” 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10” 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20” 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, In July 2017, 2017 11 Earnings per Share (Topic 260 480 815 2017 11” 480 not 2017 11 December 15, 2018, 2017 11. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 2 - Summary of Significa24

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]	For the year ended Revenue activity December 31, 2017 December 31, 2016 Set-up fees $ 4,981,941 $ 6,658,987 Change orders 1,540,167 1,212,153 Maintenance 5,107,787 4,803,171 Software licenses 10,658,977 7,885,023 Professional services 3,359,554 3,843,641 Hosting 1,331,232 1,016,535 Total $ 26,979,658 $ 25,419,510
Allowance for Credit Losses on Financing Receivables [Table Text Block]	December 31, 2017 December 31, 2016 Beginning of period $ 179,813 $ 116,834 Bad debt expense 130,346 132,767 Write-offs (160,179 ) (69,788 ) End of period $ 149,980 $ 179,813
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2017 1 10% 1 24% December 31, 2016 1 16% 2 21%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	European revenues For the year ended December 31, 2017 December 31, 2016 European revenues % of Total revenues European revenues % of Total revenues $3,632,537 14% $2,702,660 11%

Note 3 - Earnings (Loss) Per 25

Note 3 - Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Anti-dilutive security December 31, 2017 December 31, 2016 Employee stock options 4,225,000 275,000 Warrants 27,020,000 27,860,000 Convertible notes 11,980,000 15,490,000 Shares issuable for accrued interest 118,224 150,016 Total 43,343,224 43,775,016
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the year ended December 31, 2017 December 31, 2016 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 2,967,218 147,865,246 $ 0.02 $ 101,880 145,868,227 $ 0.00 Effect of dilutive securities 4,766 312,738 -0- -0- 294,200 -0- Diluted EPS $ 2,971,984 148,177,984 $ 0.02 $ 101,880 146,162,427 $ 0.00

Note 4 - Property and Equipme26

Note 4 - Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2017 December 31, 2016 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,322,833 $ 1,949,982 $ 372,851 $ 2,125,067 $ 1,761,879 $ 363,188 5 Leasehold improvements 118,380 98,901 19,479 114,719 89,789 24,930 5 Computer software 2,010,999 1,886,342 124,657 1,925,462 1,720,399 205,063 3 Office furniture 162,799 127,248 35,551 158,436 114,065 44,371 5 Total $ 4,615,011 $ 4,062,473 $ 552,538 $ 4,323,684 $ 3,686,132 $ 637,552

Note 5 - Intangible Assets, N27

Note 5 - Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2017 December 31, 2016 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 118,780 32,994 85,786 104,163 21,990 82,173 15 Promasys B.V. software code 72,837 60,698 12,139 72,837 46,130 26,707 5 Promasys B.V. URLs/website 59,990 59,990 -0- 52,608 52,608 -0- 3 Total $ 1,644,308 $ 1,546,383 $ 97,925 $ 1,622,309 $ 1,513,429 $ 108,880
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year Amortization 2018 $ 20,058 2019 7,919 2020 7,919 2021 7,919 2022 7,919 Thereafter 46,191 Total $ 97,925

Note 6 - Accounts Payable and28

Note 6 - Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Account December 31, 2017 December 31, 2016 Accounts payable $ 1,303,073 $ 697,060 Accrued payroll and related costs 925,890 886,334 Other accrued expenses 184,131 431,961 Accrued interest 172,951 107,718 Total accounts payable and accrued expenses $ 2,586,045 $ 2,123,073

Note 7 - Line of Credit, Note29

Note 7 - Line of Credit, Notes Payable and Liquidity (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Debt [Table Text Block]	Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2017 Current term Current term 2/29/2016 4/1/2019 12% $ 400,000 $ -0- $ -0- $ -0- $ 400,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 282,500 -0- 282,500 -0- -0- Discount on notes payable -0- (279,402 ) -0- (117,365 ) Total $ 1,102,500 $ -0- $ 423,098 $ -0- $ 282,635 Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate December 31, 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336

Note 8 - Convertible Notes Pa30

Note 8 - Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	Year Amount 2018 $ 50,000 2019 150,000 2020 5,770,000 2021 200,000 Total $ 6,170,000
Convertible Debt [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2017 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2019 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2020 12% 4,000,000 -0- -0- 4,000,000 -0- 12/16/2008 4/1/2021 12% 200,000 -0- -0- -0- 200,000 Total $ 6,170,000 $ -0- $ 50,000 $ 5,770,000 $ 350,000 Carrying amount Date of Maturity Interest Principal at Short term Long term issuance date rate December 31, 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000

Note 9 - Fair Value Measureme31

Note 9 - Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Fair value at Quoted prices in active markets for identical assets/liabilities Significant other observable inputs Significant unobservable inputs December 31, 2017 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 1,685,947 $ -0- $ -0- $ 1,685,947 Warrant liability 3,440,799 -0- -0- 3,440,799 Total of derivative liabilities $ 5,126,746 $ -0- $ -0- $ 5,126,746 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2016 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Risk free interest rate 1.56% to 1.81% Dividend yield 0.00% Expected volatility 87.0% to 118.4% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25
Fair Value Measurements, Nonrecurring [Table Text Block]	Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2016 December 31, 2017 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 82,173 $ 85,786 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 26,707 12,139 -0- -0- 72,943 Total $ 108,880 $ 97,925 $ -0- $ -0- $ 209,196 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 December 31, 2016 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]	Other income/(expense) For the year ended December 31, 2017 December 31, 2016 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gain/(losses) from changes in derivative liabilities at the reporting date $ 795,779 $ (2,657,910 ) Total unrealized and realized gains/(losses) included in earnings $ 795,779 $ (2,657,910 )
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Level 3 financial liabilities at fair value Net Reclassification purchases, of conversion Balance, issuances feature liability Balance, For the year ended beginning Net realized Net unrealized and associated with end December 31, 2017 of year gains/(losses) gains/(losses) settlements convertible debt of year Derivatives: Conversion feature liability $ (2,325,730 ) $ 48,375 $ 188,841 $ -0- $ 402,567 $ (1,685,947 ) Warrant liability (3,999,362 ) -0- 558,563 -0- -0- (3,440,799 ) Total of derivative liabilities $ (6,325,092 ) $ 48,375 $ 747,404 $ -0- $ 402,567 $ (5,126,746 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 )

Note 10 - Commitments and Con32

Note 10 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Year Payments 2018 $ 651,376 2019 475,638 2020 339,287 2021 269,962 2022 266,000 Thereafter 44,549 Total $ 2,046,812
Schedule Of Minimum Royalty Payments [Table Text Block]	Year Payment 2018 $ 112,500 Total $ 112,500

Note 12 - Stockholders' (Defi33

Note 12 - Stockholders' (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule Of Dividends In Arrears [Table Text Block]	Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2017 2016 2017 2016 Series B $ 609,887 $ 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 2,081,980
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	December 31, 2017 December 31, 2017 Warrants outstanding Warrants exercisable Weighted average Weighted Weighted Range of exercise price Number outstanding remaining contractual life average exercise price Number exercisable average exercise price $0.25 – $0.60 27,020,000 1.84 $ 0.42 27,020,000 $ 0.42 December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted Weighted Range of exercise price Number outstanding remaining contractual life average exercise price Number exercisable average exercise price $0.25 – $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42
Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2017 2016 Stock options granted during the period $ 0.21 $ 0.19 Stock options vested during the period $ 0.20 $ 0.21 Stock options forfeited during the period $ 0.13 $ 0.28
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2015 $ (366,355 ) $ (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 (410,505 ) (410,505 ) 2017 Activity 13,268 13,268 Balance at December 31, 2017 $ (397,237 ) $ (397,237 )
Warrant [Member]
Notes Tables
Share-based Compensation, Activity [Table Text Block]	Warrants Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Issued -0- Exercised -0- Expired/forfeited (840,000 ) Balance at December 31, 2017 27,020,000 Warrants exercisable at December 31, 2017 27,020,000 Weighted average fair value of warrants granted during 2017 n/a

Note 13 - Employee Equity Inc34

Note 13 - Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2015 2,002,500 $ 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 0.17 2.62 $ 83,425 Granted 4,650,000 0.26 Exercised (300,000 ) 0.13 Forfeited/cancelled/expired (300,000 ) 0.14 Outstanding at December 31, 2017 5,275,000 $ 0.26 4.09 $ 130,475 Vested and exercisable at December 31, 2017 400,000 $ 0.19 1.42 $ 32,638
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2017 62,500 $ 12,742 December 31, 2016 162,500 $ 33,622
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Awards breakdown by price range at December 31, 2017 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 300,000 1.93 $ 0.18 250,000 1.48 $ 0.17 0.21 to 0.30 4,250,000 4.12 0.25 150,000 1.30 0.22 0.31 to 0.50 725,000 4.82 0.34 -0- 0.00 0.00 0.00 to 0.50 5,275,000 4.09 $ 0.26 400,000 1.42 $ 0.19 Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.30 375,000 3.70 0.23 112,500 1.67 0.21 0.31 to 0.50 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.50 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the year ended Stock option assumptions December 31, 2017 December 31, 2016 Risk-free interest rate 1.81% 1.45% Expected dividend yield 0.0% 0.0% Expected volatility 127.1% 155.5% Expected life of options (in years) 5 5
Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2017 2016 Stock options granted during the period $ 0.21 $ 0.19 Stock options vested during the period $ 0.20 $ 0.21 Stock options forfeited during the period $ 0.13 $ 0.28
Schedule of Nonvested Share Activity [Table Text Block]	Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2017 487,500 $ 0.19 Nonvested shares at December 31, 2017 4,875,000 $ 0.21

Note 14 - Income Taxes (Tables)

Note 14 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	December 31, 2017 December 31, 2016 Federal statutory rate applied to income/(loss) before income taxes $ 1,117,014 $ 38,740 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,194 1,069 Nondeductible expenses (44,845 ) 1,078,519 Change in deferred assets (35,423 ) 41,019 Change in valuation allowance (1,036,746 ) (1,158,278 ) Income tax expense/(benefit) $ 1,194 $ 1,069
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	December 31, 2017 December 31, 2016 Current tax expense/(benefit): $ 1,194 $ 1,069 Deferred tax expense/(benefit): Bad debt allowance 11,226 (23,699 ) Operating loss carryforward 1,060,942 1,140,957 Amortization of intangibles 5,482 5,482 Patent litigation settlement (40,904 ) 35,538 1,037,940 1,159,347 Valuation allowance (1,036,746 ) (1,158,278 ) Total tax expense/(benefit) $ 1,194 $ 1,069
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2017 December 31, 2016 Amortization of intangibles $ 261,771 $ 267,253 Bad debt allowance 55,436 66,662 Patent litigation liability accrual 169,709 128,804 Impact of the Tax Cuts and Jobs Act (1,699,440 ) -0- Operating loss carryforwards 17,973,631 19,034,573 Gross deferred tax assets 16,761,107 19,497,292 Valuation allowance (16,761,107 ) (19,497,292 ) Net deferred tax liability/(asset) $ -0- $ -0-

Note 1 - Organization and Nat36

Note 1 - Organization and Nature of Operations (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Research and Development Expense	$ 2,854,428	$ 2,598,962

Note 2 - Summary of Significa37

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)	Jun. 16, 2016shares	Jul. 10, 2009shares
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax		$ 13,268	$ (44,150)
Number of Reportable Segments		1
Number of Revenue Producing Activities		4
Allowance for Doubtful Accounts Receivable, Current		$ 149,980	179,813
Cash, Uninsured Amount		755,893
Revenues		26,979,658	25,419,510
Deferred Revenue		9,516,953
Deferred Revenue, Current		7,564,587	7,250,061
Advertising Expense		701,161	712,179
Research and Development Expense		$ 2,854,428	$ 2,598,962
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares		10,500,000		10,000,000
Common Stock Available for Issuance Increasing Period		9 years
Common Stock Available for Issuance, Annual Increase Percent		5.00%
Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares					7,500,000
Leasehold Improvements Computers Equipment And Furniture [Member]
Property, Plant and Equipment, Useful Life		5 years
Software Development [Member]
Property, Plant and Equipment, Useful Life		3 years
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage		10.00%	16.00%
Number of Major Customers		1	1
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Concentration Risk, Percentage		10.00%	16.00%
Revenues		$ 2,691,000	$ 4,167,000
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage		24.00%	21.00%
Number of Major Customers		1	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Concentration Risk, Percentage		24.00%	11.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer 2 [Member]
Concentration Risk, Percentage			11.00%
Minimum [Member]
Term Of Software License		3 years
Deferred Revenue, Service Contract Term		30 days
Maximum [Member]
Term Of Software License		5 years
Deferred Revenue, Service Contract Term		5 years

Note 2 - Summary of Significa38

Note 2 - Summary of Significant Accounting Policies - Revenue by Business Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues	$ 26,979,658	$ 25,419,510
Set Up Fees [Member]
Revenues	4,981,941	6,658,987
Change Orders [Member]
Revenues	1,540,167	1,212,153
Maintenance [Member]
Revenues	5,107,787	4,803,171
Software Licenses [Member]
Revenues	10,658,977	7,885,023
Professional Services [Member]
Revenues	3,359,554	3,843,641
Hosting [Member]
Revenues	$ 1,331,232	$ 1,016,535

Note 2 - Summary of Significa39

Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Account Summary (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Beginning of period	$ 179,813	$ 116,834
Bad debt expense	130,346	132,767
Write-offs	(160,179)	(69,788)
End of period	$ 149,980	$ 179,813

Note 2 - Summary of Significa40

Note 2 - Summary of Significant Accounting Policies - Customer Concentration (Details) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Sales Revenue, Net [Member]
Number of customers	1	1
Concentration risk, percentage	10.00%	16.00%
Accounts Receivable [Member]
Number of customers	1	2
Concentration risk, percentage	24.00%	21.00%

Note 2 - Summary of Significa41

Note 2 - Summary of Significant Accounting Policies - Revenue From European Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
European revenues	$ 26,979,658	$ 25,419,510
Reportable Geographical Components [Member] | Europe [Member]
European revenues	$ 3,632,537	$ 2,702,660
Concentration risk, percentage	14.00%	11.00%

Note 3 - Earnings (Loss) Per 42

Note 3 - Earnings (Loss) Per Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Weighted Average Number of Shares Outstanding, Basic	147,865,246	145,868,227
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	43,343,224	43,775,016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.19
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	0.17
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.25	$ 0.25
Debt Instrument, Convertible, Conversion Price	0.25
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	0.34
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.60	$ 0.60
Debt Instrument, Convertible, Conversion Price	$ 1.25

Note 3 - Earnings (Loss) Per 43

Note 3 - Earnings (Loss) Per Share - Reconciliation of Anti-dilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Anti-dilutive Security (in shares)	43,343,224	43,775,016
Employee Stock Option [Member]
Anti-dilutive Security (in shares)	4,225,000	275,000
Warrant [Member]
Anti-dilutive Security (in shares)	27,020,000	27,860,000
Convertible Debt Securities [Member]
Anti-dilutive Security (in shares)	11,980,000	15,490,000
Shares Issuable For Accrued Interest [Member]
Anti-dilutive Security (in shares)	118,224	150,016

Note 3 - Earnings (Loss) Per 44

Note 3 - Earnings (Loss) Per Share - Computation of Diluted Earnings Per Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Basic EPS, Income (loss) numerator	$ 2,967,218	$ 101,880
Weighted Average Number of Shares Outstanding, Basic	147,865,246	145,868,227
Basic EPS, Per-share amount (in dollars per share)	$ 0.02	$ 0
Effect of dilutive securities, Income (loss) numerator	$ 4,766	$ 0
Effect of dilutive securities, Shares denominator (in shares)	312,738	294,200
Effect of dilutive securities, Per-share amount (in dollars per share)	$ 0	$ 0
Diluted EPS, Income (loss) numerator	$ 2,971,984	$ 101,880
Diluted EPS, Shares denominator (in shares)	148,177,984	146,162,427
Diluted EPS, Per-share amount (in dollars per share)	$ 0.02	$ 0

Note 4 - Property and Equipme45

Note 4 - Property and Equipment, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Depreciation	$ 336,102	$ 302,893

Note 4 - Property and Equipme46

Note 4 - Property and Equipment, Net - Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cost	$ 4,615,011	$ 4,323,684
Accumulated Depreciation	4,062,473	3,686,132
Net Book Value	552,538	637,552
Computer And Office Equipment [Member]
Cost	2,322,833	2,125,067
Accumulated Depreciation	1,949,982	1,761,879
Net Book Value	$ 372,851	363,188
Estimated Useful Lives (Year)	5 years
Leasehold Improvements [Member]
Cost	$ 118,380	114,719
Accumulated Depreciation	98,901	89,789
Net Book Value	$ 19,479	24,930
Estimated Useful Lives (Year)	5 years
Computer Equipment [Member]
Cost	$ 2,010,999	1,925,462
Accumulated Depreciation	1,886,342	1,720,399
Net Book Value	$ 124,657	205,063
Estimated Useful Lives (Year)	3 years
Furniture and Fixtures [Member]
Cost	$ 162,799	158,436
Accumulated Depreciation	127,248	114,065
Net Book Value	$ 35,551	$ 44,371
Estimated Useful Lives (Year)	5 years

Note 5 - Intangible Assets, N47

Note 5 - Intangible Assets, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Amortization of Intangible Assets	$ 22,048	$ 37,331

Note 5 - Intangible Assets, N48

Note 5 - Intangible Assets, Net - Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cost	$ 1,644,308	$ 1,622,309
Accumulated Amortization	1,546,383	1,513,429
Net Book Value	97,925	108,880
eClinical Customer List [Member]
Cost	1,392,701	1,392,701
Accumulated Amortization	1,392,701	1,392,701
Net Book Value	$ 0	0
Finite-Lived Intangible Asset, Useful Life	3 years
Promasys B.V. Customer List [Member]
Cost	$ 118,780	104,163
Accumulated Amortization	32,994	21,990
Net Book Value	$ 85,786	82,173
Finite-Lived Intangible Asset, Useful Life	15 years
Promasys B.V. Software Code [Member]
Cost	$ 72,837	72,837
Accumulated Amortization	60,698	46,130
Net Book Value	$ 12,139	26,707
Finite-Lived Intangible Asset, Useful Life	5 years
Promasys B.V. URLs/Website [Member]
Cost	$ 59,990	52,608
Accumulated Amortization	59,990	52,608
Net Book Value	$ 0	$ 0
Finite-Lived Intangible Asset, Useful Life	3 years

Note 5 - Intangible Assets, N49

Note 5 - Intangible Assets, Net - Intangible Assets, Future Amortization Expense (Details)	Dec. 31, 2017USD ($)
2,018	$ 20,058
2,019	7,919
2,020	7,919
2,021	7,919
2,022	7,919
Thereafter	46,191
Total	$ 97,925

Note 6 - Accounts Payable and50

Note 6 - Accounts Payable and Accrued Expenses - Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Accounts payable	$ 1,303,073	$ 697,060
Accrued payroll and related costs	925,890	886,334
Other accrued expenses	184,131	431,961
Accrued interest	172,951	107,718
Total accounts payable and accrued expenses	$ 2,586,045	$ 2,123,073

Note 7 - Line of Credit, Note51

Note 7 - Line of Credit, Notes Payable and Liquidity (Details Textual) - USD ($)	Aug. 31, 2017	Dec. 14, 2016	Dec. 05, 2016	Jun. 30, 2016	Feb. 29, 2016	Mar. 18, 2013	Dec. 31, 2017	Dec. 31, 2016	Apr. 01, 2015	Feb. 03, 2015	Dec. 18, 2013
Line of Credit Facility, Maximum Borrowing Capacity						$ 2,000,000				$ 5,000,000	$ 4,000,000
Debt Instrument, Interest Rate, Stated Percentage						2.00%
Debt Instrument, Periodic Payment, Interest						$ 9,500
Long-term Line of Credit							$ 2,650,000
Line of Credit Facility, Interest Rate at Period End							3.50%
Unsecured Debt							$ 1,102,500	$ 1,242,500
Note Payable 17 [Member] | Chairman and Chief Technology Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Debt Instrument, Face Amount									$ 20,000
Repayments of Debt		$ 20,000
Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage					12.00%
Debt Instrument, Face Amount					$ 450,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.25
Extinguishment of Debt, Amount					$ 450,000
Warrants Sold During the Period			1,000,000
Repayments of Long-term Debt	$ 50,000
Warrants and Rights Outstanding					325,689
Debt Instrument, Fair Value Disclosure					$ 124,311
Amortization Period of Warrant Liabilities					3 years 30 days
Matures April 1, 2020 I [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Debt Instrument, Face Amount				$ 372,500
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,490,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.25
Repayments of Long-term Debt	$ 90,000
Warrants and Rights Outstanding				$ 246,921
Debt Instrument, Fair Value Disclosure				$ 125,579
Amortization Period of Warrant Liabilities				3 years 270 days
Matures April 1, 2020 II [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage				10.00%
Debt Instrument, Face Amount				$ 420,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,680,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.25
Warrants and Rights Outstanding				$ 278,408
Debt Instrument, Fair Value Disclosure				$ 141,592
Amortization Period of Warrant Liabilities				3 years 270 days

Note 7 - Line of Credit, Note52

Note 7 - Line of Credit, Notes Payable and Liquidity - Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Ending principal	$ 1,102,500	$ 1,242,500
Discount on notes payable
Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Long-term Debt [Member] | Related Party [Member]
Ending principal	282,635	212,336
Discount on notes payable	(117,365)	(237,664)
Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	423,098	337,215
Discount on notes payable	$ (279,402)	$ (455,285)
Notes Payable, Matures April 1, 2019 [Member]
Maturity date	Apr. 1, 2019	Apr. 1, 2019
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Ending principal	$ 400,000	$ 450,000
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Non-Related Party Current [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Non-Related Party Current [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 400,000	$ 450,000
Notes Payable, Matures April 1, 2020 I [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Ending principal	$ 420,000	$ 420,000
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	$ 420,000	$ 420,000
Notes Payable, Matures April 1, 2020 II [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Ending principal	$ 282,500	$ 372,500
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	$ 282,500	$ 372,500

Note 8 - Convertible Notes Pa53

Note 8 - Convertible Notes Payable (Details Textual) - USD ($)

Aug. 31, 2017

Jun. 30, 2017

Dec. 14, 2016

Feb. 29, 2016

Nov. 23, 2015

Nov. 19, 2015

Mar. 30, 2011

Sep. 30, 2009

Dec. 31, 1999

Aug. 31, 2017

Aug. 29, 2008

Dec. 31, 2017

Dec. 31, 2016

Jun. 30, 2016

Jun. 30, 2015

May 07, 2015

May 01, 2015

Apr. 30, 2015

Apr. 27, 2015

Apr. 01, 2015

Jan. 31, 2015

Jul. 31, 2014

Apr. 28, 2014

Apr. 21, 2014

Dec. 31, 2013

Mar. 18, 2013

Mar. 12, 2013

Mar. 06, 2013

Feb. 27, 2013

Feb. 22, 2013

Dec. 16, 2008

Jun. 30, 2008

Jun. 30, 2004

Debt Instrument, Interest Rate, Stated Percentage

2.00%

Convertible Notes Payable

$ 6,170,000

$ 7,050,000

Repayments of Notes Payable

915,000

$ 200,000

Director Mr. Wit [Member]

Class of Warrant or Right Cancelled During the Period

1,900,000

Chief Executive Officer [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Interest Payable

$ 450,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,800,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Repayments of Notes Payable

$ 50,000

Convertible Notes 10% [Member]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Convertible Notes Payable

$ 862,500

Payments of Debt Issuance Costs

119,625

Proceeds from Issuance of Debt

$ 742,875

Debt Instrument, Convertible, Conversion Price

$ 1.25

Debt Conversion, Converted Instrument, Amount

$ 812,500

Debt Conversion, Converted Instrument, Shares Issued

1,495,179

Long-term Debt, Gross

$ 50,000

Interest Payable

$ 93,210

Secured Convertible Debenture [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable

$ 1,400,000

Proceeds from Issuance of Secured Debt

$ 1,400,000

Repayments of Notes Payable

$ 200,000

Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

1,200,000

Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Convertible Notes Payable

$ 1,100,000

$ 1,100,000

$ 1,100,000

Debt Instrument, Convertible, Conversion Price

$ 0.25

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,600,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Secured Convertible Debenture [Member] | Lenders [Member]

Repayments of Convertible Debt

$ 100,000

$ 625,000

Secured Convertible Debenture [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 625,000

$ 100,000

1,200,000

Secured Convertible Debenture [Member] | Director Mr. Wit [Member]

Debt Conversion, Converted Instrument, Amount

$ 475,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,900,000

Extinguishment of Debt, Amount

$ 475,000

Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares

1,900,000

Increase (Decrease) in Notes Payable, Related Parties

$ 625,000

Convertible Debentures Issued August 2008 [Member]

Convertible Notes Payable

$ 2,270,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

1,770,000

1,770,000

Convertible Debentures Issued August 2008 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

4,540,000

Convertible Debentures Issued August 2008 [Member] | Mr. van Kesteren and Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 1,920,000

150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Non-Related Party [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures [Member] | Director Mr. Wit [Member]

Convertible Notes Payable

$ 510,000

Debt Conversion, Converted Instrument, Amount

$ 510,000

Convertible Debentures [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures [Member] | Chief Operating Officer [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable

$ 25,000

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member]

Convertible Notes Payable

4,055,000

Repayments of Convertible Debt

55,000

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

1,770,000

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable

160,000

Repayments of Convertible Debt

$ 160,000

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

150,000

Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,800,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Extinguishment of Debt, Amount

$ 450,000

Matures on April 1, 2019 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures Issued December 2008 [Member]

Convertible Notes Payable

$ 5,075,000

Convertible Debentures Issued December 2008 [Member] | Non-Related Party [Member]

Convertible Notes Payable

$ 160,000

Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 360,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Repayments of Notes Payable

55,000

Convertible Debentures Issued December 2008 [Member] | Lenders [Member]

Convertible Notes Payable

$ 100,000

$ 200,000

Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 100,000

$ 100,000

$ 200,000

4,505,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,680,000

Class of Warrant or Right Cancelled During the Period

1,680,000

Extinguishment of Debt, Amount

$ 420,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 4,475,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 160,000

$ 160,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

10,150,000

Convertible Debentures Issued December 2008 [Member] | Officers, Directors and Affiliate [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 4,980,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member]

Convertible Notes Payable

4,475,000

Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member]

Convertible Notes Payable

25,000

Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member]

Convertible Notes Payable

$ 5,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member]

Debt Instrument, Interest Rate, Stated Percentage

15000.00%

Convertible Notes Payable

$ 15,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 15,000

Convertible Debentures Issued December 2008 [Member] | President [Member]

Debt Instrument, Interest Rate, Stated Percentage

25000.00%

Convertible Notes Payable

$ 25,000

Matures April 1, 2020 II [Member] | Lenders [Member]

Convertible Notes Payable

$ 100,000

Repayments of Debt

$ 100,000

Note 8 - Convertible Notes Pa54

Note 8 - Convertible Notes Payable - Convertible Debt (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Convertible Notes Payable	$ 6,170,000	$ 7,050,000
3/26/1999	50,000	50,000
3/26/1999	5,770,000	5,825,000
3/26/1999	350,000	1,175,000
Related Party [Member]
3/26/1999	0	0
3/26/1999	5,770,000	5,825,000
Non-Related Party [Member]
3/26/1999	50,000	50,000
3/26/1999	$ 350,000	$ 1,175,000
Convertible Notes Payable 10% $50,000 [Member]
Maturity date	Jun. 30, 2004	Jun. 30, 2004
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Convertible Notes Payable	$ 50,000	$ 50,000
Convertible Notes Payable 10% $50,000 [Member] | Related Party [Member]
3/26/1999	0	0
3/26/1999	0	0
Convertible Notes Payable 10% $50,000 [Member] | Non-Related Party [Member]
3/26/1999	50,000	50,000
3/26/1999	$ 0	$ 0
Convertible Notes Payable 10% $150,000 [Member]
Maturity date	Apr. 1, 2019	Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Convertible Notes Payable	$ 150,000	$ 150,000
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member]
3/26/1999	0	0
3/26/1999	0	0
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member]
3/26/1999	0	0
3/26/1999	$ 150,000	$ 150,000
Convertible Notes Payable 10% $1,770,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Convertible Notes Payable	$ 1,770,000	$ 1,770,000
Convertible Notes Payable 10% $1,770,000 [Member] | Related Party [Member]
3/26/1999	0	0
3/26/1999	1,770,000	1,770,000
Convertible Notes Payable 10% $1,770,000 [Member] | Non-Related Party [Member]
3/26/1999	0	0
3/26/1999	$ 0	$ 0
Convertible Notes Payable12 Percent, 200,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Convertible Notes Payable	$ 4,000,000	$ 200,000
Convertible Notes Payable12 Percent, 200,000 [Member] | Related Party [Member]
3/26/1999	0	0
3/26/1999	4,000,000	0
Convertible Notes Payable12 Percent, 200,000 [Member] | Non-Related Party [Member]
3/26/1999	0	0
3/26/1999	$ 0	$ 200,000
Convertible Notes Payable 12 Percent,100,000 [Member]
Maturity date	Apr. 1, 2021	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Convertible Notes Payable	$ 200,000	$ 100,000
Convertible Notes Payable 12 Percent,100,000 [Member] | Related Party [Member]
3/26/1999	0	0
3/26/1999	0	0
Convertible Notes Payable 12 Percent,100,000 [Member] | Non-Related Party [Member]
3/26/1999	0	0
3/26/1999	$ 200,000	$ 100,000
Convertible Notes Payable 12% $4,055,000 [Member]
Maturity date		Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Convertible Notes Payable		$ 4,055,000
Convertible Notes Payable 12% $4,055,000 [Member] | Related Party [Member]
3/26/1999		0
3/26/1999		4,055,000
Convertible Notes Payable 12% $4,055,000 [Member] | Non-Related Party [Member]
3/26/1999		0
3/26/1999		$ 0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009 [Member]
Maturity date		Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Convertible Notes Payable		$ 100,000
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009 [Member] | Related Party [Member]
3/26/1999		0
3/26/1999		0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009 [Member] | Non-Related Party [Member]
3/26/1999		0
3/26/1999		$ 100,000
Convertible Notes Payable 12% $625,000 [Member]
Maturity date		Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Convertible Notes Payable		$ 625,000
Convertible Notes Payable 12% $625,000 [Member] | Related Party [Member]
3/26/1999		0
3/26/1999		0
Convertible Notes Payable 12% $625,000 [Member] | Non-Related Party [Member]
3/26/1999		0
3/26/1999		$ 625,000

Note 8 - Convertible Notes Pa55

Note 8 - Convertible Notes Payable - Convertible Debt Maturity Payments (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Total	$ 6,170,000	$ 7,050,000
Convertible Debt [Member]
2,018	50,000
2,019	150,000
2,020	5,770,000
2,021	200,000
Total	$ 6,170,000

Note 9 - Fair Value Measureme56

Note 9 - Fair Value Measurement (Details Textual)	12 Months Ended
	Dec. 31, 2017
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life	15 years

Note 9 - Fair Value Measureme57

Note 9 - Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($)		Dec. 31, 2017	[2]	Dec. 31, 2016	[3]
Derivative Liability fair value	[1]	$ 5,126,746		$ 6,325,092
Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	5,126,746		6,325,092
Conversion Feature Liability [Member]
Derivative Liability fair value	[1]	1,685,947		2,325,730
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	1,685,947		2,325,730
Warrant Liability [Member]
Derivative Liability fair value	[1]	3,440,799		3,999,362
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	$ 3,440,799		$ 3,999,362
[1]	The fair value at the measurement date is equal to the carrying value on the balance sheet
[2]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the nine month period ended December 31, 2017
[3]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2016

Note 9 - Fair Value Measureme58

Note 9 - Fair Value Measurement - Fair Value Assumptions (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Dividend yield	0.00%	0.00%
Minimum [Member]
Risk free interest rate	1.56%	0.82%
Expected volatility	87.00%	117.30%
Minimum [Member] | Conversion Feature Liability [Member]
Expected life (Year)	1 year 91 days	1 year 91 days
Minimum [Member] | Warrant Liability [Member]
Expected life (Year)	91 days	91 days
Maximum [Member]
Risk free interest rate	1.81%	1.45%
Expected volatility	118.40%	143.80%
Maximum [Member] | Conversion Feature Liability [Member]
Expected life (Year)	3 years 91 days	3 years 91 days
Maximum [Member] | Warrant Liability [Member]
Expected life (Year)	3 years 91 days	3 years 91 days

Note 9 - Fair Value Measureme59

Note 9 - Fair Value Measurement - Fair Value of Assets Acquired on Non-recurring Basis (Details) - USD ($)		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Promasys B.V. customer list	[1],[2]	$ 85,786	$ 82,173	$ 92,444
Promasys B.V. software code	[1],[2]	12,139	26,707	41,274
Total	[2]	97,925	108,880	148,877
Promasys B.V. URLs/website	[1],[2]		0	$ 15,159
Fair Value, Inputs, Level 1 [Member]
Promasys B.V. customer list	[1],[2]	0	0
Promasys B.V. software code	[1],[2]	0	0
Total	[2]	0	0
Promasys B.V. URLs/website	[1],[2]		0
Fair Value, Inputs, Level 2 [Member]
Promasys B.V. customer list	[1],[2]	0	0
Promasys B.V. software code	[1],[2]	0	0
Total	[2]	0	0
Promasys B.V. URLs/website	[1],[2]		0
Fair Value, Inputs, Level 3 [Member]
Promasys B.V. customer list	[1],[2]	136,253	136,253
Promasys B.V. software code	[1],[2]	72,943	72,943
Total	[2]	$ 209,196	278,010
Promasys B.V. URLs/website	[1],[2]		$ 68,814
[1]	The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction.
[2]	The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied.

Note 9 - Fair Value Measureme60

Note 9 - Fair Value Measurement - Unrealized Gain or Loss Included in Earnings (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gain/(losses) from changes in derivative liabilities at the reporting date	$ 795,779	$ (2,657,910)

Note 9 - Fair Value Measureme61

Note 9 - Fair Value Measurement - Change in Level 3 Financial Liabilities Fair Value (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Balance, beginning of year	$ (6,325,092)	$ (2,816,166)
Net realized gains/(losses)	48,375	29,108
Net unrealized gains/(losses) relating to instruments still held at the reporting date	747,404	(2,687,018)
Net purchases, issuances and settlements	0	(851,016)
Net transfers in and/or out of Level 3	402,567	0
Balance, end of period	(5,126,746)	(6,325,092)
Conversion Feature Liability [Member]
Balance, beginning of year	(2,325,730)	(901,243)
Net realized gains/(losses)	48,375	29,108
Net unrealized gains/(losses) relating to instruments still held at the reporting date	188,841	(1,453,595)
Net purchases, issuances and settlements	0	0
Net transfers in and/or out of Level 3	402,567	0
Balance, end of period	(1,685,947)	(2,325,730)
Warrant Liability [Member]
Balance, beginning of year	(3,999,362)	(1,914,923)
Net realized gains/(losses)	0	0
Net unrealized gains/(losses) relating to instruments still held at the reporting date	558,563	(1,233,423)
Net purchases, issuances and settlements	0	(851,016)
Net transfers in and/or out of Level 3	0	0
Balance, end of period	$ (3,440,799)	$ (3,999,362)

Note 10 - Commitments and Con62

Note 10 - Commitments and Contingencies (Details Textual)	Dec. 31, 2017USD ($)$ / sharesshares	Jun. 23, 2009USD ($)	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)
Operating Leases, Rent Expense			$ 1,125,147	$ 1,071,363
Loss Contingency, Pending Claims, Number	6,496,827		6,496,827
Proceeds from Warrant Exercises			$ 155,000	0
License Payments		$ 300,000
Additional Income (Expense) Related to Settlement Agreement			$ 108,702	$ (94,129)
Settlement and Licensing Agreement [Member]
Patent Royalty Percentage Obligation			2.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	1,000,000		1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.01		$ 0.01
Loss Contingency, Estimate of Possible Loss	$ 300,000		$ 300,000
Class of Warrant or Right, Percentage, Exercised for Stock	50.00%
Stock Issued During Period, Shares, Exercise of Warrants | shares	500,000
Class of Warrant or Right, Percentage, Exercised for Cash Payment	50.00%
Proceeds from Warrant Exercises	$ 145,000

Note 10 - Commitments and Con63

Note 10 - Commitments and Contingencies - Future Minimum Lease Payments (Details)	Dec. 31, 2017USD ($)
2,018	$ 651,376
2,019	475,638
2,020	339,287
2,021	269,962
2,022	266,000
Thereafter	44,549
Total	$ 2,046,812

Note 10 - Commitments and Con64

Note 10 - Commitments and Contingencies - Minimum Royalty Payments Per Year (Details)	Dec. 31, 2017USD ($)
2,018	$ 112,500
Total	$ 112,500

Note 11 - Related Party Trans65

Note 11 - Related Party Transactions (Details Textual) - USD ($)	Aug. 31, 2017	Nov. 19, 2015	Mar. 18, 2013	Dec. 16, 2008	Aug. 29, 2008	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2016	Feb. 29, 2016	Apr. 30, 2015	Apr. 01, 2015	Feb. 03, 2015	Jan. 31, 2015	Dec. 31, 2013	Dec. 18, 2013	Feb. 22, 2013	Oct. 16, 2012	Sep. 30, 2009	Jun. 30, 2008	Feb. 29, 2008
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Convertible Notes Payable						$ 6,170,000	$ 7,050,000
Repayments of Notes Payable						915,000	200,000
Line of Credit Facility, Maximum Borrowing Capacity			$ 2,000,000									$ 5,000,000			$ 4,000,000
Long-term Line of Credit						$ 2,650,000
Line of Credit Facility, Interest Rate at Period End						3.50%
Interest Expense, Related Party						$ 947,688	$ 918,189
The Northern Trust Company [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 2,000,000									$ 5,000,000			$ 4,000,000
Line of Credit Facility, Interest Rate During Period			2.00%
Long-term Line of Credit						$ 2,650,000
Line of Credit Facility, Interest Rate at Period End						3.50%
Director Mr. Wit [Member]
Class of Warrant or Right Cancelled During the Period		1,900,000
Interest Expense, Related Party Approximately Monthly Amount			$ 9,500
Chief Executive Officer [Member]
Notes Payable, Related Parties									$ 450,000
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights									1,800,000
Repayments of Notes Payable	$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.25
Interest Payable									$ 450,000
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage											12.00%
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member]
Notes Payable, Related Parties											$ 20,000
Convertible Debentures [Member] | Chief Operating Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Convertible Notes Payable										$ 25,000
Convertible Debentures [Member] | Director Mr. Wit [Member]
Convertible Notes Payable																			$ 510,000
Due to Related Parties						$ 5,770,000
Debt Conversion, Converted Instrument, Amount					$ 510,000
Promissory Notes [Member] | CEO And Director [Member]
Notes Payable, Related Parties						$ 400,000
Convertible Debenture Initiated In June 2008 [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage					10.00%
Convertible Notes Payable					$ 1,260,000			$ 1,770,000					$ 1,770,000			$ 1,770,000		$ 1,770,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					3,540,000
Debt Instrument, Convertible, Conversion Price					$ 0.50
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties																				$ 150,000
Convertible Notes Payable													4,475,000			4,475,000	$ 125,000	$ 4,350,000		$ 4,200,000
Debt Conversion, Converted Instrument, Amount				$ 4,350,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,680,000		8,700,000													250,000
Debt Instrument, Convertible, Conversion Price				$ 0.50
Debt Conversion, Converted Instrument, Rate				12.00%
Extinguishment of Debt, Amount		$ 420,000
Class of Warrant or Right Cancelled During the Period		1,680,000
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable								$ 4,055,000
Convertible Debentures Issued December 2008 [Member]
Convertible Notes Payable				$ 5,075,000
Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable														$ 360,000
Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member]
Convertible Notes Payable																5,000
Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member]
Convertible Notes Payable																25,000
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,680,000
Extinguishment of Debt, Amount		$ 420,000
Class of Warrant or Right Cancelled During the Period		1,680,000
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable													$ 4,475,000
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Repayments of Notes Payable	$ 55,000
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member]
Convertible Notes Payable																$ 4,475,000

Note 12 - Stockholders' (Defi66

Note 12 - Stockholders' (Deficit) (Details Textual)	Dec. 31, 2017USD ($)$ / sharesshares	Sep. 29, 2017shares	Aug. 02, 2017shares	Jun. 26, 2017shares	Mar. 24, 2017shares	Dec. 30, 2016shares	Jul. 20, 2016shares	Jun. 16, 2016shares	Apr. 26, 2016shares	Apr. 25, 2016shares	Apr. 13, 2016shares	Dec. 31, 2015shares	Apr. 30, 2016shares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015shares	Dec. 31, 2014shares	Dec. 31, 1999shares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / sharesshares	Nov. 30, 2010shares	Mar. 31, 2002shares	Feb. 28, 2002shares	Aug. 31, 2001shares
Common Stock, Shares Authorized	500,000,000													500,000,000	500,000,000				500,000,000	500,000,000
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000													10,000,000	10,000,000				10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Common Stock, Shares, Issued	148,542,805													148,542,805	147,786,917				148,542,805	148,542,805
Class of Warrant or Right, Outstanding	27,020,000											22,900,000		27,020,000	27,860,000	22,900,000			27,020,000	27,020,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	5,275,000											2,002,500		5,275,000	1,225,000	2,002,500			5,275,000	5,275,000
Convertible Debt | $	$ 6,170,000													$ 6,170,000					$ 6,170,000	$ 6,170,000
Debt Instrument, Convertible, Number of Equity Instruments														12,240,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period														300,000	1,120,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $														$ 2,081,980	$ 2,081,980
Conversion of Series A Preferred Stock into Common Shares [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities													14,615,696
Conversion of Stock, Shares Converted													3,637,724
DataSci [Member]
Class of Warrant or Right, Percentage, Exercised for Stock	50.00%
Stock Issued During Period, Shares, Exercise of Warrants	500,000
Equity Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period														5 years
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		50,000	100,000	22,556			3,038		1,594	1,000,000	3,012
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		100,000				100,000
Former Employee [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period					16,668
Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities													14,615,696		14,615,696	1,950,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period														250,000	1,100,000
Stock Issued During Period, Shares, Exercise of Warrants														500,000
Conversion of Stock, Shares Converted																487,500
Common Stock [Member] | Director [Member] | Equity Incentive Plan 2009 [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross								360,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period								3 years
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	5,000,000													5,000,000	5,000,000			5,000,000	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage														5.00%		5.00%	5.00%	5.00%
Preferred Stock, Shares Outstanding	0													0	0				0	0
Preferred Stock, Shares Issued	0													0	0				0	0
Convertible Preferred Stock, Conversion Price | $ / shares														$ 1.11
Convertible Preferred Stock, Conversion Term														1 year
Convertible Preferred Stock, Stock Price Trigger | $ / shares														$ 3
Convertible Preferred Stock, Threshold Consecutive Trading Days														20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 1													$ 1					$ 1	$ 1
Preferred Stock, Liquidation Preference Per Share | $ / shares	$ 1													$ 1					$ 1	$ 1
Voting Rights, Number of Votes														1
Conversion of Stock, Shares Converted																	235,000
Number of Shareholders, Exchange Offer Initiated												34
Convertible Preferred Stock, Shares Issued upon Conversion												4				4
Number of Shareholders, Exchange Offer Accepted																4
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized	230,000													230,000	230,000				230,000	230,000			230,000	200,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage														8.00%
Preferred Stock, Shares Outstanding	0													0	0				0	0
Preferred Stock, Shares Issued	0													0	0				0	0
Convertible Preferred Stock, Stock Price Trigger | $ / shares														$ 0.50
Convertible Preferred Stock, Threshold Consecutive Trading Days														20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 10													$ 10					$ 10	$ 10
Preferred Stock, Liquidation Preference Per Share | $ / shares	10													$ 10					10	$ 10
Voting Rights, Number of Votes														1
Conversion of Stock, Shares Converted																				200,000
Share Price | $ / shares	$ 0.25													$ 0.25					$ 0.25	$ 0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $														$ 25,000,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $														$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares														$ 3.05	$ 3.05
Voting Rights, Number of Members of Board of Congress														1
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized	747,500													747,500	747,500				747,500	747,500		747,500
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage														8.00%
Preferred Stock, Shares Outstanding	0													0	0				0	0
Preferred Stock, Shares Issued	0													0	0				0	0
Convertible Preferred Stock, Threshold Consecutive Trading Days														20 days
Preferred Stock, Redemption Price Per Share | $ / shares	$ 10													$ 10					$ 10	$ 10
Preferred Stock, Liquidation Preference Per Share | $ / shares	10													$ 10					$ 10	10
Voting Rights, Number of Votes														1
Conversion of Stock, Shares Converted																			337,150
Share Price | $ / shares	$ 0.25													$ 0.25					$ 0.25	$ 0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $														$ 25,000,000
Preferred Stock, Amount of Preferred Dividends in Arrears | $														$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares														$ 4.37	$ 4.37
Voting Rights, Number of Members of Board of Congress														2
Convertible Preferred Stock, Offering Price Threshold Ratio														2.5
Series D Preferred Stock [Member]
Preferred Stock, Shares Authorized	250,000													250,000	250,000				250,000	250,000	250,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.001													$ 0.001	$ 0.001				$ 0.001	$ 0.001
Preferred Stock, Shares Outstanding	250,000													250,000	250,000				250,000	250,000
Preferred Stock, Shares Issued	250,000													250,000	250,000				250,000	250,000
Preferred Stock, Liquidation Preference Per Share | $ / shares	$ 0.001													$ 0.001					$ 0.001	$ 0.001
Voting Rights, Number of Votes														400
Preferred Stock, Right of First Refusal														30 days
Convertible Series B Preferred Stock [Member]
Share Price | $ / shares	$ 0.75													$ 0.75					$ 0.75	$ 0.75

Note 12 - Stockholders' (Defi67

Note 12 - Stockholders' (Deficit) - Cumulative Arrearage of Undeclared Dividends (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 2,081,980	$ 2,081,980
Series B Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 3.05	$ 3.05
Series C Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 4.37	$ 4.37

Note 12 - Stockholders' (Defi68

Note 12 - Stockholders' (Deficit) - Warrants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Number outstanding (in shares)	27,020,000	27,860,000	22,900,000
Weighted average remaining contractual life (Year)	1 year 306 days	2 years 259 days
Weighted average exercise price (in dollars per share)	$ 0.42	$ 0.42
Class of Warrant or Right, Exercisable (in shares)	27,020,000	27,860,000
Warrants exercisable, weighted average exercise price (in dollars per share)	$ 0.42	$ 0.42
Minimum [Member]
Range of exercise price (in dollars per share)	0.25	0.25
Maximum [Member]
Range of exercise price (in dollars per share)	$ 0.60	$ 0.60

Note 12 - Stockholders' (Defi69

Note 12 - Stockholders' (Deficit) - Warrants Activity (Details) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Balance (in shares)	27,860,000	22,900,000
Issued (in shares)	0	4,970,000
Exercised (in shares)	0	0
Expired/forfeited (in shares)	(840,000)	(10,000)
Balance (in shares)	27,020,000	27,860,000
Warrants exercisable at December 31, 2017 (in shares)	27,020,000	27,860,000

Note 12 - Stockholders' (Defi70

Note 12 - Stockholders' (Deficit) - Accumulated Other Comprehensive Gain (Loss) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Balance	$ (21,127,798)	$ (21,418,474)
Balance	(17,193,058)	(21,127,798)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance	(410,505)	(366,355)
Activity	13,268	(44,150)
Balance	(397,237)	(410,505)
AOCI Attributable to Parent [Member]
Balance	(410,505)	(366,355)
Activity	13,268	(44,150)
Balance	$ (397,237)	$ (410,505)

Note 13 - Employee Equity Inc71

Note 13 - Employee Equity Incentive Plans (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 16, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	5,275,000	1,225,000		2,002,500
Proceeds from Stock Options Exercised	$ 35,250	$ 129,500
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.21	$ 0.19
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 656,978
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 29 days
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	10,500,000		10,000,000
Common Stock Available for Issuance Increasing Period	9 years
Common Stock Available for Issuance, Annual Increase Percent	5.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years
Share-based Compensation Arrangement, Restricted Shares Granted to Employees, Number of Installments in Which Restrictions Lapse	3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,900,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,600,000
The 2016 Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period	1 year
The 2016 Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement, Installments for Vesting	2
The 2016 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	0
The 2016 Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Equity Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	7,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years
Share-based Compensation Arrangement, Installments for Vesting	2
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	375,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	0
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period	1 year
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	3,876,662
Equity Incentive Plan 2009 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years

Note 13 - Employee Equity Inc72

Note 13 - Employee Equity Incentive Plans - Stock Option Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Number of shares (in shares)	1,225,000	2,002,500
Weighted average exercise price (per share) (in dollars per share)	$ 0.17	$ 0.14
Weighted average remaining contractual term (in years) (Year)	4 years 32 days	2 years 226 days	1 year 146 days
Aggregate intrinsic value	$ 130,475	$ 83,425	$ 198,990
Number of shares, granted (in shares)	4,650,000	450,000
Weighted average exercise price (per share), granted (in dollars per share)	$ 0.26	$ 0.20
Number of shares, exercised (in shares)	(300,000)	(1,120,000)
Weighted average exercise price (per share), exercised (in dollars per share)	$ 0.13	$ 0.12
Number of shares, forfeited/cancelled/expired (in shares)	(300,000)	(107,500)
Weighted average exercise price (per share), forfeited/cancelled/expired (in dollars per share)	$ 0.14	$ 0.29
Number of shares (in shares)	5,275,000	1,225,000	2,002,500
Weighted average exercise price (per share) (in dollars per share)	$ 0.26	$ 0.17	$ 0.14
Vested and exercisable at December 31, 2017 (in shares)	400,000
Vested and exercisable at December 31, 2017 (in dollars per share)	$ 0.19
Vested and exercisable at December 31, 2017 (Year)	1 year 153 days
Vested and exercisable at December 31, 2017	$ 32,638

Note 13 - Employee Equity Inc73

Note 13 - Employee Equity Incentive Plans - Vested Shares (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Number of options vested (in shares)	62,500	162,500
Fair value of options vested	$ 12,742	$ 33,622

Note 13 - Employee Equity Inc74

Note 13 - Employee Equity Incentive Plans - Stock Options Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Low price range (in dollars per share)	$ 0	$ 0
High price range (in dollars per share)	$ 0.50	$ 0.50
Outstanding stock options (in shares)	5,275,000	1,225,000
Weighted average remaining contractual life - outstanding (Year)	4 years 32 days	2 years 226 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.26	$ 0.17
Vested stock options (in shares)	400,000	737,500
Weighted average remaining contractual life - vested (Year)	1 year 153 days	1 year 138 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.19	$ 0.15
Range One [Member]
Low price range (in dollars per share)	0	0
High price range (in dollars per share)	$ 0.20	$ 0.20
Outstanding stock options (in shares)	300,000	850,000
Weighted average remaining contractual life - outstanding (Year)	1 year 339 days	2 years 54 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.18	$ 0.15
Vested stock options (in shares)	250,000	625,000
Weighted average remaining contractual life - vested (Year)	1 year 175 days	1 year 116 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.17	$ 0.14
Range Two [Member]
Low price range (in dollars per share)	0.21	0.21
High price range (in dollars per share)	$ 0.30	$ 0.30
Outstanding stock options (in shares)	4,250,000	375,000
Weighted average remaining contractual life - outstanding (Year)	4 years 43 days	3 years 255 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.25	$ 0.23
Vested stock options (in shares)	150,000	112,500
Weighted average remaining contractual life - vested (Year)	1 year 109 days	1 year 244 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.22	$ 0.21
Range Three [Member]
Low price range (in dollars per share)	0.31	0.31
High price range (in dollars per share)	$ 0.50	$ 0.50
Outstanding stock options (in shares)	725,000	0
Weighted average remaining contractual life - outstanding (Year)	4 years 299 days	0 years
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.34	$ 0
Vested stock options (in shares)	0	0
Weighted average remaining contractual life - vested (Year)	0 years	0 years
Weighted average outstanding strike price - vested (in dollars per share)	$ 0	$ 0

Note 13 - Employee Equity Inc75

Note 13 - Employee Equity Incentive Plans - Fair Value Assumptions of Share-based Payments (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Risk-free interest rate	1.81%	1.45%
Expected dividend yield	0.00%	0.00%
Expected volatility	127.10%	155.50%
Expected life of options (in years) (Year)	5 years	5 years

Note 13 - Employee Equity Inc76

Note 13 - Employee Equity Incentive Plans - Weighted Average Grant Date Fair Value Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Stock options granted during the period (in dollars per share)	$ 0.21	$ 0.19
Stock options vested during the period (in dollars per share)	0.20	0.21
Stock options forfeited during the period (in dollars per share)	$ 0.13	$ 0.28

Note 13 - Employee Equity Inc77

Note 13 - Employee Equity Incentive Plans - Status of Non-vested Shares (Details) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Shares underlying stock options (in shares)	4,875,000	487,500
Weighted average grant date fair value (in dollars per share)	$ 0.21	$ 0.19

Note 14 - Income Taxes (Details

Note 14 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating Loss Carryforwards		$ 32,543,685
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		(2,736,185)
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability		1,699,440
Revaluation of Deferred Tax Assets (Liabilities) Due to Change in Tax Rate [Member]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ (1,699,440)
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%

Note 14 - Income Taxes - Reconc

Note 14 - Income Taxes - Reconciliation of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Federal statutory rate applied to income/(loss) before income taxes	$ 1,117,014	$ 38,740
Increase/(decrease) in income taxes results from:
Current tax expense/(benefit)	1,194	1,069
Nondeductible expenses	(44,845)	1,078,519
Change in deferred assets	(35,423)	41,019
Change in valuation allowance	(1,036,746)	(1,158,278)
Income tax expense/(benefit)	$ 1,194	$ 1,069

Note 14 - Income Taxes - Compon

Note 14 - Income Taxes - Components of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Current tax expense/(benefit)	$ 1,194	$ 1,069
Deferred tax expense/(benefit)	1,037,940	1,159,347
Change in valuation allowance	(1,036,746)	(1,158,278)
Total tax expense/(benefit)	1,194	1,069
Bad Debt Allowance [Member]
Deferred tax expense/(benefit)	11,226	(23,699)
Operating Loss Carryforward [Member]
Deferred tax expense/(benefit)	1,060,942	1,140,957
Amortization of Intangibles [Member]
Deferred tax expense/(benefit)	5,482	5,482
Patent Litigation Settlement [Member]
Deferred tax expense/(benefit)	$ (40,904)	$ 35,538

Note 14 - Income Taxes - Deferr

Note 14 - Income Taxes - Deferred Income Taxes (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Amortization of intangibles	$ 261,771	$ 267,253
Bad debt allowance	55,436	66,662
Patent litigation liability accrual	169,709	128,804
Impact of the Tax Cuts and Jobs Act	(1,699,440)	0
Operating loss carryforwards	17,973,631	19,034,573
Gross deferred tax assets	16,761,107	19,497,292
Valuation allowance	(16,761,107)	(19,497,292)
Net deferred tax liability/(asset)	$ 0	$ 0

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) - Algorithm [Member] - Subsequent Event [Member]	3 Months Ended
	Apr. 01, 2018USD ($)shares
Payments to Acquire Businesses, Gross | $	$ 500,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares	1,666,667